Tech Company Financing Transactions
Proteostasis Therapeutics Funding Round
F-Prime Capital, Genzyme Ventures and HealthCare Ventures participated in a $45 million Series A funding round for Proteostasis Therapeutics. The round was announced on 8/25/2008.
Transaction Overview
F-Prime Capital (Stephen Knight)
Genzyme Ventures (Alan Walts)
HealthCare Ventures (Christopher Mirabelli)
New Enterprise Associates (James Barrett)
Novartis BioVenture Fund (Lauren Silverman)
Company Information
Boston, MA 02135
USA
Management Team
Browse more venture capital transactions:
Prev: 8/25/2008: Demandbase venture capital transaction
Next: 8/25/2008: Sparxent venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs